AAAAAA
Results: 1-25/59
Authors:
BOWER M
ROYLANCE R
WAXMAN J
Citation: M. Bower et al., IMMUNOTHERAPY FOR RENAL-CELL CANCER, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(9), 1998, pp. 597-602
Authors:
WAXMAN J
GIBSON I
Citation: J. Waxman et I. Gibson, BRITAIN NEEDS A NATIONAL-CANCER-INSTITUTE, BMJ. British medical journal, 317(7169), 1998, pp. 1397-1397
Authors:
ROYLANCE R
WAXMAN J
Citation: R. Roylance et J. Waxman, PERSONAL VIEW - CANCER SCREENING - HOW CAN WE DO BETTER, BMJ. British medical journal, 317(7150), 1998, pp. 88-89
Authors:
WAXMAN J
ROYLANCE R
Citation: J. Waxman et R. Roylance, NEW DRUGS FOR PROSTATE-CANCER, European journal of cancer, 34(4), 1998, pp. 437-437
Authors:
SYRIGOS KN
KARAYIANNAKIS A
HARRINGTON K
WAXMAN J
PIGNATELLI M
Citation: Kn. Syrigos et al., ABNORMAL EXPRESSION OF THE E-CADHERIN-CATENIN COMPLEX CORRELATES WITHPOOR-PROGNOSIS IN BLADDER-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 96-96
Authors:
SYRIGOS KN
HARRINGTON K
WAXMAN J
KRAUSZ T
PIGNATELLI M
Citation: Kn. Syrigos et al., ALTERED GAMMA-CATENIN EXPRESSION CORRELATES WITH POOR SURVIVAL IN PATIENTS WITH BLADDER-CANCER, The Journal of urology, 160(5), 1998, pp. 1889-1893
Authors:
BOWER M
MA R
SAVAGE P
ABEL P
WAXMAN J
Citation: M. Bower et al., BRITISH UROLOGICAL SURGERY PRACTICE - 2 - RENAL, BLADDER AND TESTIS CANCER, British Journal of Urology, 81(4), 1998, pp. 513-517
Authors:
SAVAGE P
WAXMAN J
Citation: P. Savage et J. Waxman, POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE, Quarterly Journal of Medicine, 90(8), 1997, pp. 497-503
Authors:
NICHOLSON S
WAXMAN J
Citation: S. Nicholson et J. Waxman, PROSTATE-CANCER AND ENDOCRINE THERAPY, Endocrine-related cancer, 4(2), 1997, pp. 141-152
Authors:
WAXMAN J
Citation: J. Waxman, INTRODUCTION - BASIC SCIENCE ASPECTS OF PROSTATE-CANCER, Seminars in cancer biology, 8(1), 1997, pp. 1-1
Authors:
BOWER M
WAXMAN J
Citation: M. Bower et J. Waxman, GENE-THERAPY FOR PROSTATE-CANCER, Seminars in cancer biology, 8(1), 1997, pp. 3-9
Authors:
BENGTSSON NO
FOCAN C
GUDGEON A
ILLIGER HJ
KHAYAT D
MURRAY R
NORTIER JWR
WAXMAN J
ZIELINSKI C
Citation: No. Bengtsson et al., A PHASE-III TRIAL COMPARING VOROZOLE (RIVIZOR(TM)) VERSUS AMINOGLUTETHIMIDE IN THE TREATMENT OF ADVANCED POSTMENOPAUSAL BREAST-CANCER, European journal of cancer, 33, 1997, pp. 656-656
Authors:
WARE MA
STUBBS AP
BHANGAL G
WAXMAN J
ABEL PD
STAMP GWH
LALANI EN
Citation: Ma. Ware et al., SEQUENCE-ANALYSIS OF THE ANDROGEN RECEPTOR EXON-1 CAG TRINUCLEOTIDE REPEATS IN SEVERAL CELL-LINES (PROSTATIC AND NON-PROSTATIC) AND IN MICRODISSECTED PROSTATIC ADENOCARCINOMAS, Journal of pathology, 181, 1997, pp. 35-35
Authors:
WANG O
LALANI EN
POWELL S
WAXMAN J
ABEL P
JACKSON D
STAMP GWH
Citation: O. Wang et al., FGF8 MESSENGER-RNA EXPRESSION IN BENIGN AND MALIGNANT PROSTATE - RELATIONSHIP TO ANDROGEN RECEPTOR STATUS, Journal of pathology, 181, 1997, pp. 35-35
Authors:
NIGHTINGALE J
KOUMARINOU A
WAXMAN J
ABEL PD
LALANI EN
STAMP GWH
Citation: J. Nightingale et al., INTEGRIN PROFILES OF PROSTATIC CARCINOMAS AND PROSTATIC CELL-LINES, Journal of pathology, 181, 1997, pp. 51-51
Authors:
FYSSAS I
SYRIGOS KN
KONSTANDOULAKIS MM
PAPADOPOULOS S
MILINGOS N
ANAPLIOTOU M
WAXMAN J
GOLEMATIS BC
Citation: I. Fyssas et al., SEX-HORMONE LEVELS IN THE SERUM OF PATIENTS WITH PANCREATIC ADENOCARCINOMA, Hormone and Metabolic Research, 29(3), 1997, pp. 115-118
Authors:
SAVAGE P
BATES C
ABEL P
WAXMAN J
Citation: P. Savage et al., BRITISH UROLOGICAL SURGERY PRACTICE .1. PROSTATE-CANCER, British Journal of Urology, 79(5), 1997, pp. 749-754
Authors:
PAPAMICHAEL D
GALLAGHER CJ
OLIVER RTD
JOHNSON PW
WAXMAN J
Citation: D. Papamichael et al., PHASE-II STUDY OF PACLITAXEL IN PRETREATED PATIENTS WITH LOCALLY ADVANCED METASTATIC CANCER OF THE BLADDER AND URETER/, British Journal of Cancer, 75(4), 1997, pp. 606-607
Authors:
LANDOR M
LASHINSKY A
WAXMAN J
Citation: M. Landor et al., QUINOLONE ALLERGY, Annals of allergy, asthma, & immunology, 77(4), 1996, pp. 273-276
Authors:
WAXMAN J
PANDHA H
Citation: J. Waxman et H. Pandha, DO WE KNOW WHATS BEST FOR PROSTATE-CANCER, European journal of cancer, 32A(9), 1996, pp. 1455-1456
Authors:
SAVAGE P
WAXMAN J
Citation: P. Savage et J. Waxman, PSA AND PROSTATE-CANCER DIAGNOSIS, European journal of cancer, 32A(7), 1996, pp. 1097-1099
Authors:
PANDHA HS
WAXMAN J
Citation: Hs. Pandha et J. Waxman, OCTREOTIDE IN MALIGNANT INTESTINAL-OBSTRUCTION, Anti-cancer drugs, 7, 1996, pp. 5-10
Authors:
RAJKUMAR T
STAMP GWH
PANDHA HS
WAXMAN J
GULLICK WJ
Citation: T. Rajkumar et al., EXPRESSION OF THE TYPE-1 TYROSINE KINASE GROWTH-FACTOR RECEPTORS EGF RECEPTOR, C-ERBB2 AND C-ERBB3 IN BLADDER-CANCER, Journal of pathology, 179(4), 1996, pp. 381-385
Authors:
STUBBS AP
LALANI EN
STAMPA GWH
HURST H
ABEL P
WAXMAN J
Citation: Ap. Stubbs et al., 2ND MESSENGER UP-REGULATION OF ANDROGEN RECEPTOR GENE-TRANSCRIPTION IS ABSENT IN ANDROGEN INSENSITIVE HUMAN PROSTATIC-CARCINOMA CELL-LINES,PC-3 AND DU-145 (VOL 383, PG 237, 1996), FEBS letters, 390(2), 1996, pp. 240-240
Authors:
STUBBS AP
LALANI EN
STAMP GWH
HURST H
ABEL P
WAXMAN J
Citation: Ap. Stubbs et al., 2ND-MESSENGER UP-REGULATION OF ANDROGEN RECEPTOR GENE-TRANSCRIPTION IS ABSENT IN ANDROGEN INSENSITIVE HUMAN PROSTATIC-CARCINOMA CELL-LINES,PC-3 AND DU-145, FEBS letters, 383(3), 1996, pp. 237-240